Efficacy of coupled plasma filtration adsorption (CPFA) in patients with septic shock: A multicenter randomised controlled clinical trial

BMJ Open - Tập 4 Số 1 - Trang e003536 - 2014
Sergio Livigni1, Guido Bertolini2, Carlotta Rossi2, Fiorenza Ferrari3, Michele Giardino2, Marco Pozzato4, Giuseppe Remuzzi2
1Servizio Anestesia e Rianimazione B-DEA, Ospedale San Giovanni Bosco, Torino, Italy
2IRCCS-Istituto di Ricerche Farmacologiche “Mario Negri”: Centro di Ricerche Cliniche per le Malattie Rare Aldo e Cele Daccò
3Ospedale San Giovanni Bosco
4Servizio di Nefrologia e Dialisi, Ospedale San Giovanni Bosco

Tóm tắt

ObjectivesCoupled plasma filtration adsorption (CPFA, Bellco, Italy), to remove inflammatory mediators from blood, has been proposed as a novel treatment for septic shock. This multicenter, randomised, non-blinded trial compared CPFA with standard care in the treatment of critically ill patients with septic shock.DesignProspective, multicenter, randomised, open-label, two parallel group and superiority clinical trial.Setting18 Italian adult, general, intensive care units (ICUs).ParticipantsOf the planned 330 adult patients with septic shock, 192 were randomised to either have CPFA added to the standard care, or not. The external monitoring committee excluded eight ineligible patients who were erroneously included.InterventionsCPFA was to be performed daily for 5 days, lasting at least 10 h/day.Primary and secondary outcome measuresThe primary endpoint was mortality at discharge from the hospital at which the patient last stayed. Secondary endpoints were: 90-day mortality, new organ failures and ICU-free days within 30 days.ResultsThere was no statistical difference in hospital mortality (47.3% controls, 45.1% CPFA; p=0.76), nor in secondary endpoints, namely the occurrence of new organ failures (55.9% vs 56.0%; p=0.99) or free-ICU days during the first 30 days (6.8 vs 7.5; p=0.35). The study was terminated on the grounds of futility. Several patients randomised to CPFA were subsequently found to be undertreated. An a priori planned subgroup analysis showed those receiving a CPFA dose >0.18 L/kg/day had a lower mortality compared with controls (OR 0.36, 95% CI 0.13 to 0.99).ConclusionsCPFA did not reduce mortality in patients with septic shock, nor did it positively affect other important clinical outcomes. A subgroup analysis suggested that CPFA could reduce mortality, when a high volume of plasma is treated. Owing to the inherent potential biases of such a subgroup analysis, this result can only be viewed as a hypothesis generator and should be confirmed in future studies.ClinicalTrials.govNCT00332371;ISRCTN24534559.

Từ khóa


Tài liệu tham khảo

10.1128/IAI.71.10.5803-5813.2003

10.1186/cc5783

10.1001/archinte.167.15.1655

10.1056/NEJMra1208623

10.1136/bmj.326.7383.262

10.1067/msy.2000.104118

Tamayo, 2011, Pro- and anti-inflammatory responses are regulated simultaneously from the first moments of septic shock, Eur Cytokine Netw, 22, 82, 10.1684/ecn.2011.0281

10.1016/S0140-6736(04)17667-8

10.1056/NEJMra021333

10.1179/096805106X102246

10.1074/jbc.M909168199

10.1002/eji.1830210928

10.1046/j.1526-0968.2002.00413.x

10.1097/00003246-200005000-00045

10.1097/00003246-200206000-00015

10.1007/s00134-003-1724-0

Human Medicines Evaluation Unit. Guidelines for good clinical practice. London: European Agency for the Evaluation of Medical Products, 1996:17–20.

10.1007/s00134-003-1662-x

Boffelli, 2006, Continuous quality improvement in intensive care medicine. The GiViTI Margherita Project—Report 2005, Minerva Anestesiol, 72, 419

10.1097/CCM.0b013e318169ed30

10.1001/jama.1993.03510240069035

10.1097/00003246-199811000-00016

Bellomo R, Ronco C, Kellum JA, et al. Acute renal failure – definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Crit Care 2004;8:R204–12.

Piantadosi S . Clinical trial. A methodological perspective. New York: Jonh Wiley & Sons, 1997.

10.1016/S0140-6736(02)07750-4

10.1007/BF03034056

10.1159/000073444

Formica, 2007, Coupled plasma filtration adsorption, Contrib Nephrol, 156, 405, 10.1159/000102131

Kleinbaum D Kupper L Morgenstern H . Epidemiologic research. New York, NY: Van Nostrand Reynhold, 1982.

10.1136/bmj.325.7365.652

10.1186/cc9415

10.1164/rccm.2201087

10.1097/00003246-200104000-00039

10.1001/jama.1995.03530040066043

10.1007/BF01704703

10.1007/s00134-011-2438-3

Mariano, 2011, Citrate anticoagulation for continuous renal replacement therapy in critically Ill patients: success and limits, Int J Nephrol, 2011, 748320, 10.4061/2011/748320

10.1159/000078788

Pozzato M Ferrari F Cecere P . Safety and efficacy of citrate anticoagulation in spetic shock patients treated with couplet plasma filtration adsorbtion (CPFA). J Am Soc Nephrol 2011;22—Congress Proceeding:605A.

Thông tin
Thông tin xuất bản

BMJ Open

Tập 4 Số 1

e003536

Thông tin tác giả